Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.
Tumor necrosis factor-alpha (TNF) has been unequivocally validated as a therapeutic target in a number of immune-mediated inflammatory disorders (IMIDs). There is now increasing choice of biologic agents within the class all of which successfully neutralize sTNF. But approaches to TNF inhibition dif...
Egile nagusia: | Taylor, P |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2010
|
Antzeko izenburuak
-
Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases.
nork: Taylor, P
Argitaratua: (2001) -
TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
nork: Maini, R, et al.
Argitaratua: (1997) -
The effect of TNF blockade on insulin resistance in patients with rheumatoid arthritis
nork: Edwards, C, et al.
Argitaratua: (2006) -
Cytokine blockade in rheumatoid arthritis.
nork: Feldmann, M, et al.
Argitaratua: (2001) -
TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases
nork: Bystrom, J, et al.
Argitaratua: (2016)